Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
Titel:
Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
Auteur:
Iavarone, M. Tosetti, G. Facchetti, F. Topa, M. Lombardi, A. D'Ambrosio, R. Degasperi, E. Loglio, A. Oggioni, C. Bandera, A. Gori, A. Ceriotti, F. Scudeller, L. Bertoletti, A. Lampertico, P.